IBDEI05S ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7486,0)
 ;;=584.7^^40^480^1
 ;;^UTILITY(U,$J,358.3,7486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7486,1,4,0)
 ;;=4^584.7
 ;;^UTILITY(U,$J,358.3,7486,1,5,0)
 ;;=5^AC Ren Fail w/Lesion Medull Necr
 ;;^UTILITY(U,$J,358.3,7486,2)
 ;;=^338530
 ;;^UTILITY(U,$J,358.3,7487,0)
 ;;=584.6^^40^480^3
 ;;^UTILITY(U,$J,358.3,7487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7487,1,4,0)
 ;;=4^584.6
 ;;^UTILITY(U,$J,358.3,7487,1,5,0)
 ;;=5^AC Renal Fail w/Lesion of Renal Cort
 ;;^UTILITY(U,$J,358.3,7487,2)
 ;;=^338529
 ;;^UTILITY(U,$J,358.3,7488,0)
 ;;=584.6^^40^480^2
 ;;^UTILITY(U,$J,358.3,7488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7488,1,4,0)
 ;;=4^584.6
 ;;^UTILITY(U,$J,358.3,7488,1,5,0)
 ;;=5^AC Renal Fail w/Lesion Tubular Necro
 ;;^UTILITY(U,$J,358.3,7488,2)
 ;;=^338529
 ;;^UTILITY(U,$J,358.3,7489,0)
 ;;=585.6^^40^481^6
 ;;^UTILITY(U,$J,358.3,7489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7489,1,4,0)
 ;;=4^585.6
 ;;^UTILITY(U,$J,358.3,7489,1,5,0)
 ;;=5^End Stage Renal Disease
 ;;^UTILITY(U,$J,358.3,7489,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,7490,0)
 ;;=586.^^40^481^7
 ;;^UTILITY(U,$J,358.3,7490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7490,1,4,0)
 ;;=4^586.
 ;;^UTILITY(U,$J,358.3,7490,1,5,0)
 ;;=5^Renal Failure NOS
 ;;^UTILITY(U,$J,358.3,7490,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,7491,0)
 ;;=585.1^^40^481^1
 ;;^UTILITY(U,$J,358.3,7491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7491,1,4,0)
 ;;=4^585.1
 ;;^UTILITY(U,$J,358.3,7491,1,5,0)
 ;;=5^CHR Kid Dis,Stage I
 ;;^UTILITY(U,$J,358.3,7491,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,7492,0)
 ;;=585.2^^40^481^2
 ;;^UTILITY(U,$J,358.3,7492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7492,1,4,0)
 ;;=4^585.2
 ;;^UTILITY(U,$J,358.3,7492,1,5,0)
 ;;=5^CHR Kid Dis,Stage II
 ;;^UTILITY(U,$J,358.3,7492,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,7493,0)
 ;;=585.3^^40^481^3
 ;;^UTILITY(U,$J,358.3,7493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7493,1,4,0)
 ;;=4^585.3
 ;;^UTILITY(U,$J,358.3,7493,1,5,0)
 ;;=5^CHR Kid Dis,Stage III
 ;;^UTILITY(U,$J,358.3,7493,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,7494,0)
 ;;=585.4^^40^481^4
 ;;^UTILITY(U,$J,358.3,7494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7494,1,4,0)
 ;;=4^585.4
 ;;^UTILITY(U,$J,358.3,7494,1,5,0)
 ;;=5^CHR Kid Dis,Stage IV
 ;;^UTILITY(U,$J,358.3,7494,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,7495,0)
 ;;=585.5^^40^481^5
 ;;^UTILITY(U,$J,358.3,7495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7495,1,4,0)
 ;;=4^585.5
 ;;^UTILITY(U,$J,358.3,7495,1,5,0)
 ;;=5^CHR Kid Dis,Stage V
 ;;^UTILITY(U,$J,358.3,7495,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,7496,0)
 ;;=V01.79^^40^482^6
 ;;^UTILITY(U,$J,358.3,7496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7496,1,4,0)
 ;;=4^V01.79
 ;;^UTILITY(U,$J,358.3,7496,1,5,0)
 ;;=5^Viral Dis Contact
 ;;^UTILITY(U,$J,358.3,7496,2)
 ;;=^331577
 ;;^UTILITY(U,$J,358.3,7497,0)
 ;;=V01.89^^40^482^1
 ;;^UTILITY(U,$J,358.3,7497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7497,1,4,0)
 ;;=4^V01.89
 ;;^UTILITY(U,$J,358.3,7497,1,5,0)
 ;;=5^Contact Other Comm Disease
 ;;^UTILITY(U,$J,358.3,7497,2)
 ;;=^328661
 ;;^UTILITY(U,$J,358.3,7498,0)
 ;;=V01.71^^40^482^4
 ;;^UTILITY(U,$J,358.3,7498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7498,1,4,0)
 ;;=4^V01.71
 ;;^UTILITY(U,$J,358.3,7498,1,5,0)
 ;;=5^Varicella Contact/Exp
 ;;^UTILITY(U,$J,358.3,7498,2)
 ;;=^331576
 ;;^UTILITY(U,$J,358.3,7499,0)
 ;;=V01.79^^40^482^5
 ;;^UTILITY(U,$J,358.3,7499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7499,1,4,0)
 ;;=4^V01.79
 ;;^UTILITY(U,$J,358.3,7499,1,5,0)
 ;;=5^Viral Dis Cont/Exp NEC
 ;;^UTILITY(U,$J,358.3,7499,2)
 ;;=^331577
 ;;^UTILITY(U,$J,358.3,7500,0)
 ;;=V01.83^^40^482^2
 ;;^UTILITY(U,$J,358.3,7500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7500,1,4,0)
 ;;=4^V01.83
 ;;^UTILITY(U,$J,358.3,7500,1,5,0)
 ;;=5^E. Coli Contact/Exp
 ;;^UTILITY(U,$J,358.3,7500,2)
 ;;=^331578
 ;;^UTILITY(U,$J,358.3,7501,0)
 ;;=V01.84^^40^482^3
 ;;^UTILITY(U,$J,358.3,7501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7501,1,4,0)
 ;;=4^V01.84
 ;;^UTILITY(U,$J,358.3,7501,1,5,0)
 ;;=5^Meningococcus Contact
 ;;^UTILITY(U,$J,358.3,7501,2)
 ;;=^331579
 ;;^UTILITY(U,$J,358.3,7502,0)
 ;;=250.00^^40^483^1
 ;;^UTILITY(U,$J,358.3,7502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7502,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,7502,1,5,0)
 ;;=5^DM II w/o Complications
 ;;^UTILITY(U,$J,358.3,7502,2)
 ;;=^331779
 ;;^UTILITY(U,$J,358.3,7503,0)
 ;;=250.01^^40^483^2
 ;;^UTILITY(U,$J,358.3,7503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7503,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,7503,1,5,0)
 ;;=5^DM I w/o Complications
 ;;^UTILITY(U,$J,358.3,7503,2)
 ;;=^331780
 ;;^UTILITY(U,$J,358.3,7504,0)
 ;;=250.40^^40^484^15
 ;;^UTILITY(U,$J,358.3,7504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7504,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,7504,1,5,0)
 ;;=5^DM II w/Nephropathy
 ;;^UTILITY(U,$J,358.3,7504,2)
 ;;=^331795^583.81
 ;;^UTILITY(U,$J,358.3,7505,0)
 ;;=250.41^^40^484^5
 ;;^UTILITY(U,$J,358.3,7505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7505,1,4,0)
 ;;=4^250.41
 ;;^UTILITY(U,$J,358.3,7505,1,5,0)
 ;;=5^DM I w/Nephropathy
 ;;^UTILITY(U,$J,358.3,7505,2)
 ;;=^331796^583.81
 ;;^UTILITY(U,$J,358.3,7506,0)
 ;;=250.60^^40^484^16
 ;;^UTILITY(U,$J,358.3,7506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7506,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,7506,1,5,0)
 ;;=5^DM II w/Neuropathy
 ;;^UTILITY(U,$J,358.3,7506,2)
 ;;=^331803^357.2
 ;;^UTILITY(U,$J,358.3,7507,0)
 ;;=250.61^^40^484^6
 ;;^UTILITY(U,$J,358.3,7507,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7507,1,4,0)
 ;;=4^250.61
 ;;^UTILITY(U,$J,358.3,7507,1,5,0)
 ;;=5^DM I w/Neuropathy
 ;;^UTILITY(U,$J,358.3,7507,2)
 ;;=^331804^357.2
 ;;^UTILITY(U,$J,358.3,7508,0)
 ;;=250.70^^40^484^17
 ;;^UTILITY(U,$J,358.3,7508,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7508,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,7508,1,5,0)
 ;;=5^DM II w/PVD
 ;;^UTILITY(U,$J,358.3,7508,2)
 ;;=^331807^443.81
 ;;^UTILITY(U,$J,358.3,7509,0)
 ;;=250.71^^40^484^7
 ;;^UTILITY(U,$J,358.3,7509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7509,1,4,0)
 ;;=4^250.71
 ;;^UTILITY(U,$J,358.3,7509,1,5,0)
 ;;=5^DM I w/PVD
 ;;^UTILITY(U,$J,358.3,7509,2)
 ;;=^331808^443.81
 ;;^UTILITY(U,$J,358.3,7510,0)
 ;;=250.80^^40^484^12
 ;;^UTILITY(U,$J,358.3,7510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7510,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,7510,1,5,0)
 ;;=5^DM II w/L Leg Ulcer
 ;;^UTILITY(U,$J,358.3,7510,2)
 ;;=^331811^707.10
 ;;^UTILITY(U,$J,358.3,7511,0)
 ;;=250.81^^40^484^2
 ;;^UTILITY(U,$J,358.3,7511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7511,1,4,0)
 ;;=4^250.81
 ;;^UTILITY(U,$J,358.3,7511,1,5,0)
 ;;=5^DM I w/L Leg Ulcer
 ;;^UTILITY(U,$J,358.3,7511,2)
 ;;=^331812^707.10
 ;;^UTILITY(U,$J,358.3,7512,0)
 ;;=250.50^^40^484^18
 ;;^UTILITY(U,$J,358.3,7512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7512,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7512,1,5,0)
 ;;=5^DM II w/Retinopathy
 ;;^UTILITY(U,$J,358.3,7512,2)
 ;;=^331799^362.01
 ;;^UTILITY(U,$J,358.3,7513,0)
 ;;=250.51^^40^484^8
 ;;^UTILITY(U,$J,358.3,7513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7513,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,7513,1,5,0)
 ;;=5^DM I w/Retinopathy
 ;;^UTILITY(U,$J,358.3,7513,2)
 ;;=^331800^362.01
 ;;^UTILITY(U,$J,358.3,7514,0)
 ;;=250.50^^40^484^19
 ;;^UTILITY(U,$J,358.3,7514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7514,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7514,1,5,0)
 ;;=5^DM II w/Retinopathy NOS
 ;;^UTILITY(U,$J,358.3,7514,2)
 ;;=^331799^362.03
 ;;^UTILITY(U,$J,358.3,7515,0)
 ;;=250.51^^40^484^9
 ;;^UTILITY(U,$J,358.3,7515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7515,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,7515,1,5,0)
 ;;=5^DM I w/Retinopathy NOS
 ;;^UTILITY(U,$J,358.3,7515,2)
 ;;=^331800^362.03
 ;;^UTILITY(U,$J,358.3,7516,0)
 ;;=250.50^^40^484^13
 ;;^UTILITY(U,$J,358.3,7516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7516,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7516,1,5,0)
 ;;=5^DM II w/Mild Retinopathy
 ;;^UTILITY(U,$J,358.3,7516,2)
 ;;=^331799^362.04
 ;;^UTILITY(U,$J,358.3,7517,0)
 ;;=250.51^^40^484^3
 ;;^UTILITY(U,$J,358.3,7517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7517,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,7517,1,5,0)
 ;;=5^DM I w/Mild Retinopathy
 ;;^UTILITY(U,$J,358.3,7517,2)
 ;;=^331800^362.04
 ;;^UTILITY(U,$J,358.3,7518,0)
 ;;=250.50^^40^484^14
 ;;^UTILITY(U,$J,358.3,7518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7518,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7518,1,5,0)
 ;;=5^DM II w/Mod Retinopathy
 ;;^UTILITY(U,$J,358.3,7518,2)
 ;;=^331799^362.05
 ;;^UTILITY(U,$J,358.3,7519,0)
 ;;=250.51^^40^484^4
 ;;^UTILITY(U,$J,358.3,7519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7519,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,7519,1,5,0)
 ;;=5^DM I w/Mod Retinopathy
 ;;^UTILITY(U,$J,358.3,7519,2)
 ;;=^331800^362.05
 ;;^UTILITY(U,$J,358.3,7520,0)
 ;;=250.50^^40^484^20
 ;;^UTILITY(U,$J,358.3,7520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7520,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,7520,1,5,0)
 ;;=5^DM II w/Severe Retinopathy
 ;;^UTILITY(U,$J,358.3,7520,2)
 ;;=^331799^362.06
 ;;^UTILITY(U,$J,358.3,7521,0)
 ;;=250.51^^40^484^10
 ;;^UTILITY(U,$J,358.3,7521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7521,1,4,0)
 ;;=4^250.51
 ;;^UTILITY(U,$J,358.3,7521,1,5,0)
 ;;=5^DM I w/Severe Retinopathy
 ;;^UTILITY(U,$J,358.3,7521,2)
 ;;=^331800^362.06
 ;;^UTILITY(U,$J,358.3,7522,0)
 ;;=250.80^^40^484^11
 ;;^UTILITY(U,$J,358.3,7522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7522,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,7522,1,5,0)
 ;;=5^DM II w/Hypoglycemia
 ;;^UTILITY(U,$J,358.3,7522,2)
 ;;=^331811
 ;;^UTILITY(U,$J,358.3,7523,0)
 ;;=250.81^^40^484^1
 ;;^UTILITY(U,$J,358.3,7523,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7523,1,4,0)
 ;;=4^250.81
 ;;^UTILITY(U,$J,358.3,7523,1,5,0)
 ;;=5^DM I w/Hypoglycemia
